Static Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 00:00:00 18/06/2026 +04			5-day change	1st Jan Change
2.980 ^USD	+1.71%		+1.02%	+8.36%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

Duration

Period